Search Within

David Solit

Formats
  1. Meeting Abstract (391)
  2. Journal Article (366)
  3. Editorial (9)
  4. Book Section (4)
  5. Research Letter (4)
  6. Review (4)
  7. Correspondence (2)
  8. Guidelines (2)
  9. Conference Paper (1)
Groups
  1. Department of Medicine (783)
  2. GSK Faculty (783)
  3. Genitourinary Oncology Service (783)
  4. Human Oncology and Pathogenesis Program (783)
  5. Solid Tumor Oncology Division (783)
  6. Department of Pathology and Laboratory Medicine (510)

More Groups

People
  1. Michael Berger (317)
  2. Hikmat Al-Ahmadie (186)
  3. Gopakumar Iyer (184)
  4. Neal Rosen (155)
  5. Nikolaus Schultz (150)
  6. Dean Bajorin (130)

More People

Years
  1. 2025 (17)
  2. 2024 (38)
  3. 2023 (39)
  4. 2022 (44)
  5. 2021 (47)
  6. 2020 (59)

More Years

Publications
  1. Journal of Clinical Oncology (163)
  2. Cancer Research (99)
  3. Clinical Cancer Research (77)
  4. Laboratory Investigation (42)
  5. Modern Pathology (37)
  6. Cancer Discovery (24)

More Publications

Publishers
  1. American Association for Cancer Research (219)
  2. American Society of Clinical Oncology (181)
  3. Nature Publishing Group (97)
  4. Nature Research (39)
  5. Elsevier Inc. (31)
  6. Oxford University Press (29)

More Publishers

Results (783)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Association of somatic ERCC2 mutations with cisplatin sensitivity in muscle-invasive urothelial carcinoma
    Meeting Abstract

    Rosenberg, J. E.; Van Allen, E. M.; Mouw, K. W.; Kim, P. H.; Wagle, N.; Al-Ahmadie, H.; Zhu, C.; Ostrovnaya, I.; Iyer, G.; Signoretti, S.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase I study of oral BKM120 and oral olaparib for high-grade serous ovarian cancer (HGSC) or triple-negative breast cancer (TNBC)
    Meeting Abstract

    Matulonis, U.; Wulf, G. M.; Birrer, M. J.; Westin, S. N.; Quy, P.; Bell-Mcguinn, K. M.; Lasonde, B.; Whalen, C.; Aghajanian, C.; Solit, D. B.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Oncogenic RAF mutants that signal as functional dimers are resistant to current RAF inhibitors but sensitive to a novel inhibitor of RAF dimer kinase activity
    Meeting Abstract

    Yao, Z.; Torres, M.; Wei, M.; Hanrahan, A.; Abdel-Wahab, O.; Solit, D.; Luo, L. S.; Poulikakos, P.; Rosen, N.
    Cancer Research (2014)

    Fulltext@MSK | Save
  • A phase II study of afatinib (A) in patients (pts) with metastatic human epidermal growth factor receptor (HER2)-positive trastuzumab (T) refractory esophagogastric (EG) cancer
    Meeting Abstract

    Janjigian, Y. Y.; Imtiaz, T.; Ilson, D. H.; Solit, D. B.; Berger, M. F.; Vakiani, E.
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Frequency and function of ERBB3 mutations in bladder cancer
    Meeting Abstract

    Hanrahan, A. J.; Sfakianos, J. P.; Ramirez, R.; Kim, P. H.; Iyer, G.; Al-Ahmadie, H. A.; Scott, S. N.; Bajorin, D. F.; Bochner, B. H.; Coleman, J. A.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • The landscape of actionable genomic lesions in small cell bladder cancer
    Meeting Abstract

    Chang, M. T.; Asthana, S.; Iyer, G.; Desai, N.; Al-Ahmadie, H.; Chapman, J.; Bochner, B. H.; Rosenberg, J. E.; Bajorin, D. F.; Solit, D. B.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Loss of PTEN leads to clinical resistance to the PI3K alpha inhibitor BYL719 and provides evidence of convergent evolution under selective therapeutic pressure
    Meeting Abstract

    Castel, P.; Juric, D.; Won, H.; Ainscough, B.; Ellis, H.; Ebbesen, S.; Griffith, M.; Griffith, O.; Iyer, G.; Sgroi, D.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Loss of PTEN leads to acquired resistance to the PI3Ka inhibitor BYL719: A case of convergent evolution under selective therapeutic pressure
    Meeting Abstract

    Castel, P.; Juric, D.; Griffith, M.; Griffith, O. L.; Won, H. H.; Ainscough, B.; Ellis, H.; Ebbesen, S.; Gopakumar, I.; Quadt, C.; more...
    European Journal of Cancer (2014)

    Fulltext@MSK | Save
  • Ganetespib, a novel Hsp90 inhibitor in patients with KRAS mutated and wild type, refractory metastatic colorectal cancer
    Journal Article

    Cercek, A.; Shia, J.; Gollub, M.; Chou, J. F.; Capanu, M.; Raasch, P.; Reidy-Lagunes, D.; Proia, D. A.; Vakiani, E.; Solit, D. B.; more...
    Clinical Colorectal Cancer (2014)

    Fulltext@MSK | Save
  • Lessons from the study of extraordinary responders
    Meeting Abstract

    Solit, D. B.
    The Oncologist (2014)

    Fulltext@MSK | Save